Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury

被引：178
|
作者：
Cai, ZQ
Semenza, GL
机构：
[1] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Inst Cell Engn, Baltimore, MD 21205 USA
来源：
CIRCULATION | 2004年 / 109卷 / 17期
关键词：
erythropoietin; ischemia; reperfusion; myocardial infarction;
D O I：
10.1161/01.CIR.0000127954.98131.23
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Background - Parenteral administration of recombinant human erythropoietin (rhEPO) to rats induces protection against myocardial ischemia/reperfusion injury 24 hours later. However, the mechanisms by which rhEPO mediates protection have not been determined. Methods and Results - rhEPO was perfused into isolated rat hearts over 15 minutes immediately before 30 minutes of no-flow ischemia and 45 minutes of reperfusion. Compared with saline-perfused control hearts, recovery of left ventricular developed pressure was increased in rhEPO-perfused hearts. rhEPO also increased AKT activity and decreased apoptosis. All of these effects were blocked when the phosphatidylinositol-3-kinase inhibitor wortmannin was infused with rhEPO. Conclusions - rhEPO provides immediate protection against ischemia/reperfusion injury in the isolated perfused rat heart that is mediated by the phosphatidylinositol-3-kinase pathway.
引用
收藏
页码：2050 / 2053
页数：4
相关论文
共 50 条
  • [11] Nanoparticle-mediated targeting of phosphatidylinositol-3-kinase signaling inhibits angiogenesis
    Rania Harfouche
    Sudipta Basu
    Shivani Soni
    Dirk M. Hentschel
    Raghunath A. Mashelkar
    Shiladitya Sengupta
    Angiogenesis, 2009, 12 : 325 - 338
  • [12] Ginsenoside Rb1 Preconditioning Protects Against Myocardial Infarction After Regional Ischemia and Reperfusion by Activation of Phosphatidylinositol-3-kinase Signal Transduction
    Wang, Zhi
    Li, Min
    Wu, Wei-kang
    Tan, Hong-mei
    Geng, Deng-feng
    CARDIOVASCULAR DRUGS AND THERAPY, 2008, 22 (06) : 443 - 452
  • [13] Nanoparticle-mediated targeting of phosphatidylinositol-3-kinase signaling inhibits angiogenesis
    Harfouche, Rania
    Basu, Sudipta
    Soni, Shivani
    Hentschel, Dirk M.
    Mashelkar, Raghunath A.
    Sengupta, Shiladitya
    ANGIOGENESIS, 2009, 12 (04) : 325 - 338
  • [14] Granulocyte colony-stimulating factor mediates cardioprotection against ischemia/reperfusion injury via phosphatidylinositol-3-kinase/akt pathway in canine hearts
    Takahama, Hiroyuki
    Minamino, Tetsuo
    Hirata, Akio
    Ogai, Akiko
    Asanuma, Hiroshi
    Fujita, Masashi
    Wakeno, Masakatsu
    Tsukamoto, Osamu
    Okada, Ken-ichiro
    Komamura, Kazuo
    Takashima, Seiji
    Shinozaki, Yoshiro
    Mori, Hidezo
    Mochizuki, Naoki
    Kitakaze, Masafumi
    CARDIOVASCULAR DRUGS AND THERAPY, 2006, 20 (03) : 159 - 165
  • [15] Granulocyte Colony-Stimulating Factor Mediates Cardioprotection Against Ischemia/Reperfusion Injury via Phosphatidylinositol-3-Kinase/Akt Pathway in Canine Hearts
    Hiroyuki Takahama
    Tetsuo Minamino
    Akio Hirata
    Akiko Ogai
    Hiroshi Asanuma
    Masashi Fujita
    Masakatsu Wakeno
    Osamu Tsukamoto
    Ken-ichiro Okada
    Kazuo Komamura
    Seiji Takashima
    Yoshiro Shinozaki
    Hidezo Mori
    Naoki Mochizuki
    Masafumi Kitakaze
    Cardiovascular Drugs and Therapy, 2006, 20 : 159 - 165
  • [16] Rosiglitazone-induced myocardial protection against ischaemia-reperfusion injury is mediated via a phosphatidylinositol 3-kinase/Akt-dependent pathway
    Zhang, Xue-Jiao
    Xiong, Zi-Bo
    Tang, An-Li
    Ma, Hong
    Ma, Yue-Dong
    Wu, Jing-Guo
    Dong, Yu-Gang
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (02) : 156 - 161
  • [17] Hydrogen sulfide donor confers protection against acute myocardial ischemia-reperfusion injury
    Gundewar, Susheel
    Calvert, John W.
    Holtzman, Dvorah
    Koulogiannis, Konstantinos P.
    Bartov, David
    Jha, Saurabh
    Patel, Sandeep
    Elrod, John W.
    Lefer, David J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 222A - 223A
  • [18] Epicatechin-3-Gallate Signaling and Protection against Cardiac Ischemia/Reperfusion Injury
    Qi, Yiyao
    Yang, Changjun
    Jiang, Zhen
    Wang, Yin
    Zhu, Feng
    Li, Tao
    Wan, Xiaochun
    Xu, Yunhui
    Xie, Zijian
    Li, Daxiang
    Pierre, Sandrine, V
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2019, 371 (03): : 663 - 674
  • [19] Protection against myocardial ischemia/reperfusion injury in TLR4-deficient mice is mediated through a phosphoinositide 3-kinase-dependent mechanism
    Hua, Fang
    Ha, Tuanzhu
    Ma, Jing
    Li, Yan
    Kelley, Jim
    Gao, Xiang
    Browder, I. William
    Kao, Race L.
    Williams, David L.
    Li, Chuanfu
    JOURNAL OF IMMUNOLOGY, 2007, 178 (11): : 7317 - 7324
  • [20] Estrogen-Mediated Protection in Myocardial Ischemia-Reperfusion Injury
    Erin A. Booth
    Benedict R. Lucchesi
    Cardiovascular Toxicology, 2008, 8 : 101 - 113
12345